Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.90
-0.03 (-0.34%)
At close: May 19, 2026, 4:00 PM EDT
8.95
+0.05 (0.56%)
After-hours: May 19, 2026, 7:31 PM EDT
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$796,179
Profits / Employee
-$117,270
Market Cap
1.46B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Vir Biotechnology | 367 |
| Nuvation Bio | 307 |
| KalVista Pharmaceuticals | 275 |
| Precigen | 160 |
| GH Research | 73 |
NVAX News
- 6 days ago - Novavax Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 days ago - Novavax Slides: Corporate presentation - Filings
- 8 days ago - Hantavirus cases spark surge in pharma and biotech stocks — here's why - CNBC
- 12 days ago - Novavax to Participate in BofA Securities 2026 Health Care Conference - PRNewsWire
- 12 days ago - Novavax reports Q1 EPS (6c), consensus (23c) - TheFly
- 12 days ago - Novavax price target raised to $9 from $8 at TD Cowen - TheFly
- 13 days ago - Novavax Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - Novavax Quarterly report: Q1 2026 - Filings